Pulmonary Drug Delivery Devices Market Size will Grow Profitably in the Near Future

Due to limitations of the conventional treatment of various chronic diseases, attention has been shifted to the development of targeted drug delivery systems. Pulmonary drug delivery is one of the targeted drug delivery systems where the drug delivery is aimed at lungs for local and systemic treatment. The high permeability and large absorptive surface area of lungs, along with steady blood supply, leads to faster absorption of drugs into the bloodstream. Increased adoption of pulmonary drug delivery is expected to push the global pulmonary drug delivery systems market during the period between 2013 and 2019.

Obtain Report Details @ https://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html

Increasing Patient Base to Boost Global Pulmonary Drug Delivery Systems Market

According to the World Health Organization, around 300 million people across the globe suffer from asthma. Growing patient pool affected with respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) is one of the prime factors set to contribute to the global pulmonary drug delivery systems market.

Rapid absorption of different macromolecules and most of the therapeutic drugs over the alveolar epithelium of the distal lung has allowed pulmonary drug delivery systems to become efficacious. Technical advances in pulmonary drug delivery systems as well as drug formulations are expected to propel the overall market in the near future. Presently, the therapeutic applications of pulmonary drug delivery are expanding and this will help the market’s growth prospects.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=873

However, patent expiry of drug delivery systems and delay in obtaining approvals from regulatory authorities are expected to negatively affect the global pulmonary drug delivery systems market. During the next couple of years, developing economies will present immense market potential for pulmonary drug delivery systems, owing to the growing patient base.

Nebulizers to be Fastest Growing Segment of Global Pulmonary Drug Delivery Systems Market

On the basis of product type, the global pulmonary drug delivery systems market has been segmented into nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs). In 2012, the overall market was dominated by metered dose inhalers, which accounted for 56.8% of the market. Dry powder inhalers were the second largest segment in the market the same year. During the period between 2013 and 2019, nebulizers are expected to be the fastest growing segment of the pulmonary drug delivery systems market. In terms of application, the global pulmonary drug delivery systems market has been categorized into cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). In the coming years, the usage of pulmonary drug delivery systems for the treatment of asthma and COPD is expected to increase considerably.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=873

North America Led Global Pulmonary Drug Delivery Systems Market in 2012

Globally, the pulmonary drug delivery systems market has been divided into four key regions: Europe, Asia Pacific, North America, and Rest of the World. In 2012, North America was the leading market for pulmonary drug delivery systems, owing to the increasing patient base and robust healthcare infrastructure. During the period between 2013 and 2019, Asia Pacific is expected to contribute significantly to the growth of the market due to the growing number of people smoking tobacco. Some of the key players in the global pulmonary drug delivery systems market are CareFusion Corporation, 3M Health Care, Novartis AG, Omron Healthcare Inc., and GlaxoSmithKline.

Popular Research Reports by TMR –

Post-operative Nausea and Vomiting Market: http://markets.businessinsider.com/news/stocks/post-operative-nausea-and-vomiting-market-to-become-worth-us-3-100-mn-by-2026-says-tmr-1027343575

Sterilization Wrap Market: http://www.prnewswire.co.uk/news-releases/sterilization-equipment-market-to-gain-us-846553-mn-by-2026-says-tmr-687864421.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.